Cardiac Transplantation: Any Role Left?

Martin Cadeiras, Manuel Prinz von Bayern, Mario C. Deng

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

The authors analyze the question of whether heart transplantation still has a role in the current era of complex technologies. To achieve this objective, the authors first discuss the known benefits of different therapeutic modalities currently available for patients who have end-stage heart failure, including pharmacologic management, electrophysiologic therapies, high-risk surgical strategies, implantation of mechanical circulatory support device therapy, and heart transplantation. The authors then evaluate the current developments and future perspectives in the field that may influence the likelihood of heart transplantation to remain the therapeutic modality of choice for end-stage heart failure.

Original languageEnglish (US)
Pages (from-to)321-347
Number of pages27
JournalHeart Failure Clinics
Volume3
Issue number3
DOIs
StatePublished - Jul 1 2007
Externally publishedYes

Fingerprint

Heart Transplantation
Heart Failure
Therapeutics
Technology
Equipment and Supplies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiac Transplantation : Any Role Left? / Cadeiras, Martin; von Bayern, Manuel Prinz; Deng, Mario C.

In: Heart Failure Clinics, Vol. 3, No. 3, 01.07.2007, p. 321-347.

Research output: Contribution to journalReview article

Cadeiras, Martin ; von Bayern, Manuel Prinz ; Deng, Mario C. / Cardiac Transplantation : Any Role Left?. In: Heart Failure Clinics. 2007 ; Vol. 3, No. 3. pp. 321-347.
@article{27e450d8b35547fc9dbf767a5e879831,
title = "Cardiac Transplantation: Any Role Left?",
abstract = "The authors analyze the question of whether heart transplantation still has a role in the current era of complex technologies. To achieve this objective, the authors first discuss the known benefits of different therapeutic modalities currently available for patients who have end-stage heart failure, including pharmacologic management, electrophysiologic therapies, high-risk surgical strategies, implantation of mechanical circulatory support device therapy, and heart transplantation. The authors then evaluate the current developments and future perspectives in the field that may influence the likelihood of heart transplantation to remain the therapeutic modality of choice for end-stage heart failure.",
author = "Martin Cadeiras and {von Bayern}, {Manuel Prinz} and Deng, {Mario C.}",
year = "2007",
month = "7",
day = "1",
doi = "10.1016/j.hfc.2007.04.004",
language = "English (US)",
volume = "3",
pages = "321--347",
journal = "Heart Failure Clinics",
issn = "1551-7136",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Cardiac Transplantation

T2 - Any Role Left?

AU - Cadeiras, Martin

AU - von Bayern, Manuel Prinz

AU - Deng, Mario C.

PY - 2007/7/1

Y1 - 2007/7/1

N2 - The authors analyze the question of whether heart transplantation still has a role in the current era of complex technologies. To achieve this objective, the authors first discuss the known benefits of different therapeutic modalities currently available for patients who have end-stage heart failure, including pharmacologic management, electrophysiologic therapies, high-risk surgical strategies, implantation of mechanical circulatory support device therapy, and heart transplantation. The authors then evaluate the current developments and future perspectives in the field that may influence the likelihood of heart transplantation to remain the therapeutic modality of choice for end-stage heart failure.

AB - The authors analyze the question of whether heart transplantation still has a role in the current era of complex technologies. To achieve this objective, the authors first discuss the known benefits of different therapeutic modalities currently available for patients who have end-stage heart failure, including pharmacologic management, electrophysiologic therapies, high-risk surgical strategies, implantation of mechanical circulatory support device therapy, and heart transplantation. The authors then evaluate the current developments and future perspectives in the field that may influence the likelihood of heart transplantation to remain the therapeutic modality of choice for end-stage heart failure.

UR - http://www.scopus.com/inward/record.url?scp=34548161665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548161665&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2007.04.004

DO - 10.1016/j.hfc.2007.04.004

M3 - Review article

C2 - 17723940

AN - SCOPUS:34548161665

VL - 3

SP - 321

EP - 347

JO - Heart Failure Clinics

JF - Heart Failure Clinics

SN - 1551-7136

IS - 3

ER -